LIDE is a preclinical oncology CRO offering classical drug efficacy mouse models like CDX and more than 2200 patient derived xenograft (PDX), covering 40+ cancer types. LIDE is unique with its 200+ naturally drug resistant models, and more importantly, its proprietary MiniPDX and IO FIVE 7-day in-vivo assays. We also offer in-vitro 2D and 3D (spheroid, organoid) assays.
Founded in 2011 by overseas returnees, LIDE brings together first-class research and management teams with advanced scientific backgrounds to push the frontier of translational medical research. We operate at the forefront of new technologies and adopt the highest international accreditation standards. The company owns AAALAC accredited SPF level Animal Centers, safety level 2 laboratories and world-class, state of the art equipment.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 887 Zuchongzhi Rd, Building #77-78
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.lidebiotech.com
- Keywords
- Oncology Research, Oncology, PDX, MiniPDX, Translational Medicine, Precision medicine, Biotech, Immune-Oncology, IO, Conditionally Reprogramed Cells, In Vitro, In Vivo, AAALAC, CAP Certified.
- HQ
- Shanghai, Pudong
Lide Biotech Questions
Lide Biotech's website is http://www.lidebiotech.com
Lide Biotech's LinkedIn profile is https://www.linkedin.com/company/lide-biotech
Lide Biotech has
11 employees.
View email and phone details for 11
employees at Lide Biotech.
Lide Biotech's industry is
Biotechnology Research
Lide Biotech's top competitors are
Paro Ai, Inc,
Cliantha Research Limited,
Mercodia,
Parexel,
Syvento Biotech,
Lonza,
Vermilion Life,
Nextshift,
Society For Functional Precision Medicine,
Syneos Health.
Lide Biotech's categories are Biotechnology Research
Lide Biotech's founding year is 2011
